Pulmonx Corporation
LUNG
$7.32
$0.020.27%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 23.77M | 20.39M | 20.78M | 18.85M | 19.28M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.77M | 20.39M | 20.78M | 18.85M | 19.28M |
| Cost of Revenue | 6.18M | 5.36M | 5.48M | 4.78M | 4.88M |
| Gross Profit | 17.59M | 15.03M | 15.31M | 14.08M | 14.40M |
| SG&A Expenses | 27.01M | 25.41M | 25.31M | 24.40M | 24.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.18M | 34.52M | 36.41M | 33.39M | 33.20M |
| Operating Income | -13.42M | -14.13M | -15.62M | -14.54M | -13.92M |
| Income Before Tax | -13.14M | -13.95M | -15.24M | -13.56M | -13.64M |
| Income Tax Expenses | 38.00K | 192.00K | 84.00K | 186.00K | 248.00K |
| Earnings from Continuing Operations | -13.18M | -14.14M | -15.33M | -13.75M | -13.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.18M | -14.14M | -15.33M | -13.75M | -13.89M |
| EBIT | -13.42M | -14.13M | -15.62M | -14.54M | -13.92M |
| EBITDA | -13.12M | -13.73M | -14.42M | -14.11M | -13.63M |
| EPS Basic | -0.33 | -0.36 | -0.39 | -0.36 | -0.36 |
| Normalized Basic EPS | -0.21 | -0.22 | -0.24 | -0.22 | -0.22 |
| EPS Diluted | -0.33 | -0.36 | -0.39 | -0.36 | -0.36 |
| Normalized Diluted EPS | -0.21 | -0.22 | -0.24 | -0.22 | -0.22 |
| Average Basic Shares Outstanding | 39.58M | 39.28M | 38.94M | 38.64M | 38.38M |
| Average Diluted Shares Outstanding | 39.58M | 39.28M | 38.94M | 38.64M | 38.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
